Deutsche Bank AG acquired a new position in Aphria Inc (NYSE:APHA) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 168,882 shares of the company’s stock, valued at approximately $960,000.
Several other institutional investors and hedge funds have also bought and sold shares of APHA. ETF Managers Group LLC bought a new stake in Aphria during the 4th quarter worth approximately $15,389,000. Norges Bank bought a new stake in Aphria during the 4th quarter worth approximately $10,301,000. TD Asset Management Inc. bought a new stake in Aphria during the 4th quarter worth approximately $4,073,000. Bank of America Corp DE bought a new stake in Aphria during the 4th quarter worth approximately $2,175,000. Finally, Toronto Dominion Bank bought a new stake in Aphria during the 4th quarter worth approximately $723,000. 9.73% of the stock is currently owned by institutional investors.
A number of equities research analysts have commented on the stock. Zacks Investment Research upgraded shares of Aphria from a “strong sell” rating to a “hold” rating in a research note on Friday, May 10th. Clarus Securities initiated coverage on shares of Aphria in a research note on Tuesday, April 16th. They set a “buy” rating and a $22.75 target price on the stock. ValuEngine cut shares of Aphria from a “buy” rating to a “hold” rating in a research report on Monday, April 15th. Seaport Global Securities initiated coverage on shares of Aphria in a research report on Thursday, February 21st. They set a “buy” rating and a $18.00 price objective on the stock. Finally, Cormark set a $15.00 price objective on shares of Aphria and gave the company a “buy” rating in a research report on Saturday, February 2nd. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $15.69.
Aphria (NYSE:APHA) last released its quarterly earnings data on Monday, April 15th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.11). The firm had revenue of $55.24 million for the quarter, compared to analysts’ expectations of $41.11 million.
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
Further Reading: How do taxes affect a CDs total return?
Want to see what other hedge funds are holding APHA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aphria Inc (NYSE:APHA).
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.